Published • loading... • Updated
Aligos Therapeutics, Inc. (NASDAQ:ALGS) Stock Has Average Target Price of $38.50
Summary by thecerbatgem.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Aligos Therapeutics, Inc. (NASDAQ:ALGS) Stock Has Average Target Price of $38.50
Shares of Aligos Therapeutics, Inc. (NASDAQ:ALGS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the seven brokerages that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, five have assigned a buy rating and one has given a strong […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
